Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hypoglycemia × Diazoxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Gastrointestinal 1 Endocrine 1

Conditions

Pituitary Diseases 1 Obesity 1 Neoplasms 1 Hypoglycemia 1 Hyperinsulinism 1 Gastro-enteropancreatic neuroendocrine tumor 1 Craniopharyngioma 1

Interventions

fluorodopa F 18 3 pasireotide 1 Flour 1 Diazoxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02779257 2022-03-04

Pasireotide Treatment for Neuroendocrine Tumor

University of Maryland, Baltimore

Phase 4 Withdrawn

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Hypoglycemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡